Ventriglia, Gianluca
Duncan, Neil
Giménez, Ignacio
Mylonas, Constantinos C.
Pousis, Chrysovalentinos
Corriero, Aldo
Zupa, Rosa
Funding for this research was provided by:
H2020 (862658)
Article History
Received: 25 July 2024
Accepted: 18 April 2025
First Online: 29 April 2025
Declarations
:
: Gianluca Ventriglia, Neil Duncan, Constantinos C. Mylonas, Chrysovalentinos Pousis, Aldo Corriero and Rosa Zupa declare no competing interest. Ignacio Gimenéz is associated with the biotech company Rara Avis Biotech, S. L., which produced the recombinant gonadotropin employed in this study.